ASO Author Reflections: Contemporary Analysis of Impact of Lymphadenectomy on Survival in Nonmetastatic Gallbladder Cancer

Affiliations

¹ Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, USA. phillip.m.kempbohan.mil@mail.mil.
² Department of Surgery, William Beaumont Army Medical Center, El Paso, TX, USA.
³ Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, USA.

Phillip M Kemp Bohan et al. Ann Surg Oncol. 2021 Jun.

. 2021 Jun;28(6):2973-2974.

doi: 10.1245/s10434-021-09668-7. Epub 2021 Feb 9.

¹ Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, USA. phillip.m.kempbohan.mil@mail.mil.
² Department of Surgery, William Beaumont Army Medical Center, El Paso, TX, USA.
³ Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, USA.

No abstract available

References

1. Shroff RT, Kennedy EB, Bachini M, et al. Adjuvant therapy for resected biliary tract cancer: ASCO clinical practice guideline. J Clin Oncol. 2019;37(12):1015–27. - DOI
1. Primrose JN, Fox RP, Palmer DH, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019;20(5):663–73. - DOI
1. Edeline J, Benabdelghani M, Bertaut A, et al. Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): a randomized phase III study. J Clin Oncol. 2019;37(8):658–67. - DOI
1. Kemp Bohan PM, Kirby DT, Chick RC, et al. Adjuvant chemotherapy in resectable gallbladder cancer is underutilized despite benefits in node-positive patients. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08973-x . - DOI - PubMed
1. Kemp Bohan PM, O'Shea AE, Ellis OV, et al. Rates, predictors, and outcomes of portal lymphadenectomy in patients with resectable, non-metastatic gallbladder cancer. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-09667-8 .